Emerging Growth Conference: Imagion Biosystems Limited. (CXA: IBX) (ASX: IBX)
Imagion Biosystems Limited. (CXA: IBX) (ASX: IBX) is developing a new non-radioactive and precision diagnostic molecular imaging technology. Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible. Keynote speakers: Robert Romeo Proulx, Executive Chairman & Ward Detwiler, Chief Business Officer
0
likes
•
0
questions
•
0
company answers
Ask a question
Your question will be sent privately to Imagion Biosystems. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Imagion Biosystems a question about this update.